恒定自然杀伤T细胞参与慢性淋巴细胞白血病的免疫监视与预后
研究在Eμ-Tcl1慢性淋巴细胞白血病(CLL)小鼠模型和68例CLL患者中探讨恒定自然杀伤T(iNKT)细胞的作用,发现Tcl1-CLL细胞表达CD1d,iNKT细胞可延缓疾病发生但在疾病进展时功能受损;患者中疾病进展与CLL细胞高CD1d表达及iNKT细胞功能受损相关,而疾病稳定与CD1d阴性或低表达及正常iNKT细胞相关,多变量分析显示iNKT细胞频率是疾病进展的独立预测因素。
要点
- Tcl1-CLL细胞表达CD1d,iNKT细胞可延缓疾病发生,但疾病进展时iNKT细胞功能受损。
- CLL患者疾病进展与CLL细胞高CD1d表达及iNKT细胞功能受损相关。
- 多变量分析显示iNKT细胞频率是CLL疾病进展的独立预测因素。
核心结论
- iNKT细胞参与CLL免疫监视,其频率可作为疾病进展的预后标志物。
研究设计与样本
- 研究纳入Eμ-Tcl1(Tcl1)CLL小鼠模型和68例CLL患者,探讨iNKT细胞在疾病自然史中的作用。
主要发现
- Tcl1-CLL细胞表达CD1d,iNKT细胞关键性地延缓疾病发生,但在疾病进展时功能受损。
- 患者中疾病进展与CLL细胞高CD1d表达及iNKT细胞功能受损相关,疾病稳定与CLL细胞CD1d阴性或低表达及正常iNKT细胞相关。
- iNKT细胞通过抑制表达CD1d的护士样细胞(nurse-like cells)在体外阻碍CLL存活。
- 多变量分析确定iNKT细胞频率是疾病进展的独立预测因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic lymphocytic leukemia (CLL) is characterized by the expansion of malignant CD5+ B lymphocytes in blood, bone marrow, and lymphoid organs. CD1d-restricted invariant natural killer T (iNKT) cells are innate-like T lymphocytes strongly implicated in tumor surveillance. We investigated the impact of iNKT cells in the natural history of the disease in the Eμ-Tcl1 (Tcl1) CLL mouse model and 68 CLL patients. We found that Tcl1-CLL cells express CD1d and that iNKT cells critically delay disease onset but become functionally impaired upon disease progression. In patients, disease progression correlates with high CD1d expression on CLL cells and impaired iNKT cells. Conversely, disease stability correlates with negative or low CD1d expression on CLL cells and normal iNKT cells, suggesting indirect leukemia control. iNKT cells indeed hinder CLL survival in vitro by restraining CD1d-expressing nurse-like cells, a relevant proleukemia macrophage population. Multivariable analysis identified iNKT cell frequency as an independent predictor of disease progression. Together, these results support the contribution of iNKT cells to CLL immune surveillance and highlight iNKT cell frequency as a prognostic marker for disease progression.
引用
- Gorini F, Azzimonti L, Delfanti G, et al. Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis. Blood. 2017. PMID: 28465341. doi:10.1182/blood-2016-11-751065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。